As of Apr 2, 2025, the Incyte stock's PE ratio is 389.56. This results from the current EPS of $0.16 and stock price of $62.33. The P/E ratio has an increase of 56% from the past four quarters average of 249.3.
The PE ratio of Incyte has averaged 247.46 over the last ten years. The current PE ratio of 389.56 is 57% above the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Maximum annual increase: 1,735.42% in 2024
Maximum annual decrease: -93.28% in 2016
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 431.69 | 1,735.42% | $69.07 | $0.16 |
2023 | 23.52 | -55.2% | $62.79 | $2.67 |
2022 | 52.5 | 207.56% | $80.32 | $1.53 |
2021 | 17.07 | N/A | $73.4 | $4.3 |
2020 | N/A | N/A | $86.98 | -$1.36 |
2019 | 41.98 | -65.67% | $87.32 | $2.08 |
2018 | 122.29 | N/A | $63.59 | $0.52 |
2017 | N/A | N/A | $94.71 | -$1.53 |
2016 | 182.31 | -93.28% | $100.27 | $0.55 |
2015 | 2,711.25 | N/A | $108.45 | $0.04 |
2014 | N/A | N/A | $73.11 | -$0.29 |
2013 | N/A | N/A | $50.63 | -$0.56 |
2012 | N/A | N/A | $16.61 | -$0.34 |
2011 | N/A | N/A | $15.01 | -$1.49 |
2010 | N/A | N/A | $16.56 | -$0.26 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 431.69 | 11.03% | $69.07 | $0.16 |
Sep 2024 | 388.82 | 143.73% | $66.1 | $0.17 |
Jun 2024 | 159.53 | 832.38% | $60.62 | $0.38 |
Mar 2024 | 17.11 | -27.25% | $56.97 | $3.33 |
Dec 2023 | 23.52 | -23.06% | $62.79 | $2.67 |
Sep 2023 | 30.57 | -19.47% | $57.77 | $1.89 |
Jun 2023 | 37.96 | -23.31% | $62.25 | $1.64 |
Mar 2023 | 49.5 | -5.71% | $72.27 | $1.46 |
Dec 2022 | 52.5 | 211.94% | $80.32 | $1.53 |
Sep 2022 | 16.83 | -5.4% | $66.64 | $3.96 |
Jun 2022 | 17.79 | -5.47% | $75.97 | $4.27 |
Mar 2022 | 18.82 | 10.25% | $79.42 | $4.22 |
Dec 2021 | 17.07 | -39.68% | $73.4 | $4.3 |
Sep 2021 | 28.3 | -48.2% | $68.78 | $2.43 |
Jun 2021 | 54.63 | 47.21% | $84.13 | $1.54 |
Currently, INCY's PE ratio is greater than its 3, 5 and 10-year historical averages.
INCY's PE ratio is higher than its peer stocks LLY and NVS. Incyte's current PE ratio of 389.56 is comparable to the average of its peer group, which is 36.45.
Stock name | PE ratio | Market cap |
---|---|---|
PFE Pfizer Inc | 17.3 | $139.22B |
NVS Novartis AG | 19.05 | $222.73B |
AMGN Amgen Inc | 40.53 | $165.93B |
LLY ELI LILLY & Co | 67.94 | $757.57B |
INCY Incyte Corp | 390.19 | $12.08B |
LGND Ligand Pharmaceuticals Inc | N/A | $2.03B |
ARDX Ardelyx Inc | N/A | $1.14B |
GERN Geron Corp | N/A | $933.07M |
INCY stock has a price to earnings ratio of 389.56 as of Apr 2, 2025.
As an average over the last 3 years, INCY stock has a PE ratio of 111.44.
As an average over the last 5 years, INCY stock has a PE ratio of 86.36.
Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
INCY's price to earnings ratio is currently 57% above its 10-year historical average.
INCY's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 2, 2025), Incyte's stock price is $62.33. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.16. Therefore, Incyte's P/E ratio for today is 389.56. PE RATIO(389.56) = STOCK PRICE($62.33) / TTM EPS($0.16)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.